Rabin Martin

A global health strategy that sits on a shelf doesn’t make an impact – on your business or the people who can’t access your medicines today. ​

In today’s competitive and complex healthcare environment, leveraging Global Health expertise and partnerships, from strategy to execution, is a must-have in unlocking incremental growth.

Rabin Martin designs, develops and delivers effective solutions to unlock new markets and opportunities – creating unique ways for more people to access your therapeutics, and generating more preference and advocacy for your products among stakeholders. ​

To do this, we bring together unrivaled global health and equity expertise – with decades of experience in commercial strategy, health system strengthening, health equity, and therapeutic area expertise – from cancer and chronic disease to rare disease and maternal and child health. And we’re trained to see connections and know how to leverage local market knowledge, policy and partnerships to have a bigger impact on business and public health outcomes. ​

It’s why we’ve work with many of the top players in health, from entities within the UN, to pharma leaders like Merck/MSD and J&J, to the Rockefeller and Bill & Melinda Gates Foundations. And we’ve managed more than $2 billion in health and equity programming – across 80 markets including US, Europe and Low-to-Middle Income Countries. ​

​But we don’t just design a strategy and walk away – we follow it through to make a lasting impact. And we make it real by working side-by-side with you – managing everything from strategy and solution development, to implementation, measurement and evaluation. ​

​To Rabin Martin, health impact means more business value and societal value. ​

​Let us know how we can help. [email protected] ​

Related blog posts